Skip to main content
. 2017 Feb 21;23(7):1241–1249. doi: 10.3748/wjg.v23.i7.1241

Table 1.

Patients’ baseline characteristics

Overall SIBO (n = 12) no-SIBO (n = 27) P value
Age 53 (41-60) 55 (41-60) 57 (43-60) 0.306
Sex (males/females) 14 (35.9)/25 (64.1) 2 (16.7)/10 (83.3) 12 (44.4)/15 (55.6) 0.095
Vitamin K2 intake (μg/d) 29.5 (8-103.6) 21.2 (8-49.7) 31.9 (10.5-103.6) 0.111
Males: 25.7 (8-103.6)
Females 29.6 (10.4-91.8)
Framingham risk score 5.4 (2-8) 5.5 (2-7) 5.2 (2-8) 0.897
Males: 5.8 (2-8)
Females: 6.9 (0-8)

Data are expressed as median (range) or frequency (%). Comparisons have been performed between SIBO and no-SIBO group. Framingham score was built on age, sex, race, arterial pressure, smoking, diabetes, total blood cholesterol, HDL-cholesterol. SIBO: Small intestinal bacterial overgrowth.